MiMedx Comments on Proposed FDA Draft Guidance on Homologous Use of HCT/Ps

By: via Benzinga
MiMedx Group, Inc. (NASDAQ: MDXG) commented on the proposed Draft Guidance on Homologous Use of Human Cells, Tissues, and Cellular and ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.